Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.
By S. Oddo, A. Caccamo, Jason Shepherd, M. Murphy, Todd E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Yama Akbari, Frank M. LaFerla. Neuron, 2003
4,164 citations recorded by the source corpus.
The neuropathological correlates of Alzheimer's disease (AD) include amyloid-beta (Abeta) plaques and neurofibrillary tangles. To study the interaction between Abeta and tau and their effect on synaptic function, we derived a triple-transgenic model (3xTg-AD) harboring PS1(M146V), APP(Swe), and tau(P301L) transgenes. Rather than crossing independent lines, we microinjected two transgenes into single-cell embryos from homozygous PS1(M146V) knockin mice, generating mice with the same genetic background. 3xTg-AD mice progressively develop plaques and tangles. Synaptic dysfunction, including LTP deficits, manifests in an age-related manner, but before plaque and tangle pathology. Deficits in long-term synaptic plasticity correlate with the accumulation of intraneuronal Abeta. These studies suggest a novel pathogenic role for intraneuronal Abeta with regards to synaptic plasticity. The recapitulation of salient features of AD in these mice clarifies the relationships between Abeta, synaptic dysfunction, and tangles and provides a valuable model for evaluating potential AD therapeutics as the impact on both lesions can be assessed.
Subfields: Cellular and Molecular Neuroscience, Developmental Neuroscience, Physiology
View Paper: https://www.semanticscholar.org/paper/62fa9ab30dce5132ef1c4939beb87c2ccd6f41d1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Developmental Neuroscience
In Physiology
Citations in the corpus
- Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity (2011, result): “Our data complement those obtained in another triple transgenic mouse model, 3xTgAD (P301Ltau/APPSw/PS1 M146L) [70].”
- Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation (2006, methodology): “This work was supported by National Institute on Aging Grants P01 AG021184 (Project 1, L.V.E.; Project 4, R.V.; Histology Core, R.B.) and R01 AG022560 (R.V.) We are indebted to Lynn Doglio and her staff at the Northwestern Transgenic and Targeted Mutagenesis Laboratory for transgene microinjection a”
- Mechanisms of tau-induced neurodegeneration (2009, neutral): “Consistent with this hypothesis, both intracerebral infusion of Ab in FTDP-17 tau mutation P301L-expressing transgenic mice, as well as crossing these animals with APPTg2576 mice (APP Swedish plus London mutations), were found to exacerbate neurofibrillary pathology [54, 104] and, in the triple tran”
- APP processing in Alzheimer's disease (2011, result): “Studies with transgenic mouse models consistently confirm these results, revealing intracellular Ab accumulation as an early event in the neuropathological phenotype with decreasing intraneuronal levels of Ab as extracellular plaques build up [150-152].”
- Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice (2005, positive): “ormed as described in Oddo et al. (2004). Mice were excluded”
- APP mouse models for Alzheimer's disease preclinical studies (2017, neutral): “Oddo et al (2003) generated a triple Tg model, 3xTg-AD mice, which overexpress APP swe , and Tau P301L transgenes on a PS1 M146V knock-in background.”
- Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers (2006, background): “For instance, triple transgenic mice (PS1M146V, APPSWE, tauP301L) develop Aβ pathology prior to tau alterations, despite using the same promoter to drive expression of mutant human APP and tau (Oddo et al. 2003).”